NEU NEWMARKET CORP
Industrial Organic Chemicals · NYSE · SEC CIK 1282637 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY0.9%
TTM net income YoY2.0%
TTM EPS YoY4.1%
Revenue 3-yr CAGR0.4%
Net income 3-yr CAGR4.6%
Margins
Gross margin31.7%
Operating margin20.2%
Net margin16.5%
FCF margin13.8%
EBITDA margin24.8%
Returns
ROE25.3%
ROA13.3%
ROIC (approx.)17.3%
Asset turnover0.80x
Leverage & solvency
Liabilities / assets47.1%
Debt / equity0.43x
Current ratio2.46x
Interest coverage15.79x
Cash quality & payout
Operating cash flow / net income1.09x
Accruals ratio-1.2%
Payout ratio24.4%
Capex / revenue4.2%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $2.73B | $2.79B | $2.70B | $2.76B | $2.36B |
| Cost of revenue | $1.87B | $1.90B | $1.93B | $2.12B | $1.81B |
| Gross profit | $857.40M | $886.35M | $772.51M | $640.50M | $547.71M |
| R&D expense | $132.09M | $124.90M | $138.00M | $140.25M | $143.95M |
| SG&A expense | $181.58M | $171.41M | $151.47M | $145.11M | $145.97M |
| Operating income | $543.73M | $590.04M | $483.05M | $355.14M | $257.78M |
| Interest expense | $39.69M | $57.37M | $37.36M | $35.20M | $34.22M |
| Pretax income | $560.56M | $584.11M | $488.96M | $347.73M | $247.55M |
| Income tax | $141.81M | $121.69M | $100.10M | $68.20M | $56.64M |
| Net income | $418.75M | $462.41M | $388.86M | $279.54M | $190.91M |
| EBITDA | $666.15M | $706.99M | $561.05M | $437.42M | $342.10M |
| EPS (basic) | 44.44 | 48.22 | 40.44 | 27.77 | 17.71 |
| EPS (diluted) | 44.44 | 48.22 | 40.44 | 27.77 | 17.71 |
| Dividends declared per share | 11.25 | 10.00 | 8.85 | 8.40 | 8.00 |
| Weighted avg. shares (diluted) | 9.39M | 9.55M | 9.58M | 10.04M | 10.76M |
| Balance sheet | |||||
| Cash & equivalents | $77.60M | $77.48M | $111.94M | $68.71M | $83.30M |
| Short-term investments | — | — | — | $0 | $375.92M |
| Receivables | $422.08M | $395.45M | $432.35M | $453.69M | $391.78M |
| Inventory | $502.26M | $505.43M | $456.23M | $631.38M | $498.54M |
| Current assets | $1.06B | $1.03B | $1.04B | $1.19B | $1.39B |
| PP&E, net | $775.48M | $735.36M | $654.75M | $660.00M | $676.77M |
| Total assets | $3.49B | $3.13B | $2.31B | $2.41B | $2.56B |
| Current liabilities | $419.28M | $374.48M | $364.16M | $423.89M | $725.09M |
| Short-term debt | — | — | — | $0 | $349.43M |
| Long-term debt | $883.39M | $971.28M | $643.62M | $1.00B | $789.85M |
| Total debt | $883.39M | $971.28M | $643.62M | $1.00B | $1.14B |
| Total liabilities | $1.71B | $1.67B | $1.23B | $1.64B | $1.80B |
| Shareholders' equity | $1.78B | $1.46B | $1.08B | $762.41M | $762.13M |
| Net debt | $805.79M | $893.80M | $531.69M | $935.02M | $1.06B |
| Shares outstanding | 9.40M | 9.52M | 9.59M | 9.70M | 10.36M |
| Cash flow statement | |||||
| Operating cash flow | $568.97M | $519.59M | $576.82M | $108.62M | $165.34M |
| Capital expenditure | $77.64M | $57.32M | $48.29M | $56.17M | $78.93M |
| Free cash flow | $491.33M | $462.27M | $528.53M | $52.45M | $86.40M |
| Investing cash flow | -$291.08M | -$738.80M | -$48.29M | $315.89M | -$461.41M |
| Financing cash flow | -$279.14M | $185.81M | -$487.59M | -$439.36M | $255.13M |
| Depreciation & amortization | $122.42M | $116.96M | $78.01M | $82.28M | $84.32M |
| Dividends paid | $105.93M | $95.90M | $85.03M | $84.26M | $85.91M |
| Share buybacks | $77.22M | $31.91M | $42.86M | $207.47M | $196.22M |
Free plan shows the latest 5 periods; Pro shows all 18 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.